Michitaka Nakashima

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The emergence of drug-resistant tumors during treatment remains one of the major obstacles in cancer chemotherapy. Overexpression of P-glycoprotein encoded by the multidrug resistance 1 (MDR1) gene or multidrug resistance-associated protein (MRP) (or both) and decreased expression of DNA topoisomerase II are responsible for expression of the multidrug(More)
  • 1